为什么TCR-T细胞疗法表现出优越的抗瘤疗效?
Dandan Yang1, Zhihui Duan1, Ping Yuan1
1Laboratory of Structural Immunology, Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
Biochemical and biophysical research communications
|November 9, 2023
概括
用T细胞受体 (TCR) 进行的T细胞疗法在固体瘤中显示出前景. 新抗原特异性TCR-T细胞疗法,除了优化瘤微环境和TCR外,为癌症治疗提供了一个有前途的未来方向.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 用T细胞受体 (TCR) 设计的T细胞疗法在治疗固体瘤方面取得了重大进展,一些方法进入临床试验.
- 了解TCR-T细胞治疗的现状对于指导未来的研究和临床应用至关重要.
研究的目的:
- 审查TCR-T细胞治疗在固体瘤治疗中的进展.
- 为了分类瘤抗原并分析针对这些抗原的TCR-T细胞疗法.
- 探索增强TCR-T细胞治疗疗效的策略.
主要方法:
- 瘤抗原被分为四类:与瘤相关的,瘤特异的,瘤性病毒表达的和与异常蛋白质修饰相关的.
- 在针对这些抗原的临床和临床前试验中详细审查TCR-T细胞治疗效应.
- 优化策略的总结,以改善TCR-T细胞疗法.
主要成果:
- 新抗原特异性TCR-T细胞疗法被认为是对固体瘤的一种非常有前途的方法.
- 针对不同抗原类型的各种TCR-T细胞疗法在试验中显示出有效性.
- 优化策略,包括调节瘤微环境和增强TCR配对和亲和力,对于治疗成功至关重要.
结论:
- 在固体瘤治疗中,TCR-T细胞疗法代表了显著的进步.
- 用TCR工程T细胞向新抗原对未来的癌症治疗有很大的潜力.
- 对抗原选择和治疗优化的进一步研究对于最大限度地提高TCR-T细胞治疗的影响至关重要.
相关概念视频
Tumor Immunotherapy
533
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
533
Cytotoxic T Cells-mediated Immune Response
928
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
928
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

